23 May 2013
Keywords: avanir, neurodex, sees, strong, ph, iii, data
Article | 08 May 2006
The USA's Avanir Pharmaceuticals says that strong data were reported on Neurodex, its drug candidate for involuntary emotional expression
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 April 2006
© 2013 thepharmaletter.com